Cargando…
Advances in Mammalian Cell Line Development Technologies for Recombinant Protein Production
From 2006 to 2011, an average of 15 novel recombinant protein therapeutics have been approved by US Food and Drug Administration (FDA) annually. In addition, the expiration of blockbuster biologics has also spurred the emergence of biosimilars. The increasing numbers of innovator biologic products a...
Autores principales: | Lai, Tingfeng, Yang, Yuansheng, Ng, Say Kong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817724/ https://www.ncbi.nlm.nih.gov/pubmed/24276168 http://dx.doi.org/10.3390/ph6050579 |
Ejemplares similares
-
Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster ovary cells
por: Chin, Christine Lin, et al.
Publicado: (2015) -
HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
por: Tan, Evan, et al.
Publicado: (2021) -
Editorial: Technological Advances Improving Recombinant Protein Production in Bacteria
por: Ow, Dave Siak-Wei, et al.
Publicado: (2021) -
Multiplexed expression and screening for recombinant protein production in mammalian cells
por: Chapple, Susan DJ, et al.
Publicado: (2006) -
Engineering selection stringency on expression vector for the production of recombinant human alpha1-antitrypsin using Chinese Hamster Ovary cells
por: Chin, Christine L, et al.
Publicado: (2015)